CDH1 and neoplasm: Importantly, we provided direct experimental support: silencing MIR4435-2HG impaired tumor proliferation, migration, invasion, and reversed EMT and immune evasion phenotypes (upregulation of E-cadherin; downregulation of Vimentin and PD-L1).